Global Herpes Zoster Infection Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 116 pages | ID: GA1195A56EFEN
GlobalInfoResearch

Abstracts

Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many years after the occurrence of chicken pox infection and is as reactive as Herpes Zoster.

Scope of the Report:

This report studies the Herpes Zoster Infection Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Herpes Zoster Infection Treatment market by product type and applications/end industries.
Chickenpox is caused by initial infection of VZV virus, after chicken pox is resolved the virus remains inactive in the nerve cells. The virus gets reactive travels to the nerve end producing blisters. The rash increases within two or three weeks. Herpes zoster appear as blisters on one side of the body usually on neck, face or torso. Some symptoms beyond pain and rashes are fever, headache, fatigue and muscles weakness. Person who had chicken pox is at risk of herpes zoster. The person with the herpes zoster can pass on the virus to someone else who never had chicken pox, but the person will develop chicken pox and not herpes zoster.
Herpes zoster is prevalent in older adults usually between 60 to 80 years as they have weak immune system. People undergoing radiation therapy or chemotherapy weakens the immune system and are more prone to herpes zoster disease. The diagnosis of the herpes zoster is done by laboratory test to detect the VZV antibody in the blood. After the diagnosis of the herpes zoster medication is given for the treatment which include oral medicines, topical and vaccines.  Antihistamines, numbing creams, gels, or patches are given to reduce the pain. Vaccines are mostly given to the older people who have a higher risk of getting the herpes zoster
The global Herpes Zoster Infection Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Herpes Zoster Infection Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Valeant Pharmaceuticals
• Camber Pharmaceuticals
• Novartis
• Teva Pharmaceutical
• Abbott
• Merck

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Oral
• Topical
• Parental

Market Segment by Applications, can be divided into

• Clinics
• Hospitals
• Diagnostic centers
• Home Care

Contents

1 HERPES ZOSTER INFECTION TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Herpes Zoster Infection Treatment
1.2 Classification of Herpes Zoster Infection Treatment by Types
  1.2.1 Global Herpes Zoster Infection Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Types in 2017
  1.2.3 Oral
  1.2.4 Topical
  1.2.5 Parental
1.3 Global Herpes Zoster Infection Treatment Market by Application
  1.3.1 Global Herpes Zoster Infection Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Clinics
  1.3.3 Hospitals
  1.3.4 Diagnostic centers
  1.3.5 Home Care
1.4 Global Herpes Zoster Infection Treatment Market by Regions
  1.4.1 Global Herpes Zoster Infection Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Herpes Zoster Infection Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Valeant Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Herpes Zoster Infection Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Valeant Pharmaceuticals Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Camber Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Herpes Zoster Infection Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Camber Pharmaceuticals Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
  2.3.1 Business Overview
  2.3.2 Herpes Zoster Infection Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Novartis Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical
  2.4.1 Business Overview
  2.4.2 Herpes Zoster Infection Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Teva Pharmaceutical Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott
  2.5.1 Business Overview
  2.5.2 Herpes Zoster Infection Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Abbott Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
  2.6.1 Business Overview
  2.6.2 Herpes Zoster Infection Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Merck Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HERPES ZOSTER INFECTION TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Herpes Zoster Infection Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Herpes Zoster Infection Treatment Players Market Share
  3.2.2 Top 10 Herpes Zoster Infection Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL HERPES ZOSTER INFECTION TREATMENT MARKET SIZE BY REGIONS

4.1 Global Herpes Zoster Infection Treatment Revenue and Market Share by Regions
4.2 North America Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HERPES ZOSTER INFECTION TREATMENT REVENUE BY COUNTRIES

5.1 North America Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
5.2 USA Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE HERPES ZOSTER INFECTION TREATMENT REVENUE BY COUNTRIES

6.1 Europe Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
6.2 Germany Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
6.4 France Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HERPES ZOSTER INFECTION TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
7.2 China Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
7.5 India Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HERPES ZOSTER INFECTION TREATMENT REVENUE BY COUNTRIES

8.1 South America Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
8.2 Brazil Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HERPES ZOSTER INFECTION TREATMENT BY COUNTRIES

9.1 Middle East and Africa Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL HERPES ZOSTER INFECTION TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Herpes Zoster Infection Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Herpes Zoster Infection Treatment Market Forecast by Type (2018-2023)
10.3 Oral Revenue Growth Rate (2013-2023)
10.4 Topical Revenue Growth Rate (2013-2023)
10.5 Parental Revenue Growth Rate (2013-2023)

11 GLOBAL HERPES ZOSTER INFECTION TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Herpes Zoster Infection Treatment Revenue Market Share by Application (2013-2018)
11.2 Herpes Zoster Infection Treatment Market Forecast by Application (2018-2023)
11.3 Clinics Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Diagnostic centers Revenue Growth (2013-2018)
11.6 Home Care Revenue Growth (2013-2018)

12 GLOBAL HERPES ZOSTER INFECTION TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Herpes Zoster Infection Treatment Market Size Forecast (2018-2023)
12.2 Global Herpes Zoster Infection Treatment Market Forecast by Regions (2018-2023)
12.3 North America Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
12.6 South America Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Herpes Zoster Infection Treatment Picture
Table Product Specifications of Herpes Zoster Infection Treatment
Table Global Herpes Zoster Infection Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Herpes Zoster Infection Treatment Revenue Market Share by Types in 2017
Figure Oral Picture
Figure Topical Picture
Figure Parental Picture
Table Global Herpes Zoster Infection Treatment Revenue (Million USD) by Application (2013-2023)
Figure Herpes Zoster Infection Treatment Revenue Market Share by Applications in 2017
Figure Clinics Picture
Figure Hospitals Picture
Figure Diagnostic centers Picture
Figure Home Care Picture
Table Global Market Herpes Zoster Infection Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Herpes Zoster Infection Treatment Type and Applications
Table Valeant Pharmaceuticals Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Camber Pharmaceuticals Herpes Zoster Infection Treatment Type and Applications
Table Camber Pharmaceuticals Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Herpes Zoster Infection Treatment Type and Applications
Table Novartis Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Herpes Zoster Infection Treatment Type and Applications
Table Teva Pharmaceutical Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Herpes Zoster Infection Treatment Type and Applications
Table Abbott Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Herpes Zoster Infection Treatment Type and Applications
Table Merck Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Herpes Zoster Infection Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue Share by Players (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Share by Players in 2016
Figure Global Herpes Zoster Infection Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Herpes Zoster Infection Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Herpes Zoster Infection Treatment Revenue Market Share in 2017
Figure Global Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Market Share by Regions in 2017
Figure North America Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure South America Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Table North America Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
Table North America Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Herpes Zoster Infection Treatment Revenue Market Share by Countries in 2017
Figure USA Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Table Europe Herpes Zoster Infection Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Herpes Zoster Infection Treatment Revenue Market Share by Countries in 2017
Figure Germany Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure UK Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure France Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Herpes Zoster Infection Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Herpes Zoster Infection Treatment Revenue Market Share by Countries in 2017
Figure China Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure India Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Table South America Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)
Table South America Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Herpes Zoster Infection Treatment Revenue Market Share by Countries in 2017
Figure Brazil Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Herpes Zoster Infection Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Herpes Zoster Infection Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Herpes Zoster Infection Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue Share by Type (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Share by Type (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Share by Type in 2017
Table Global Herpes Zoster Infection Treatment Revenue Forecast by Type (2018-2023)
Figure Global Herpes Zoster Infection Treatment Market Share Forecast by Type (2018-2023)
Figure Global Oral Revenue Growth Rate (2013-2018)
Figure Global Topical Revenue Growth Rate (2013-2018)
Figure Global Parental Revenue Growth Rate (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue by Application (2013-2018)
Table Global Herpes Zoster Infection Treatment Revenue Share by Application (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Share by Application (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue Share by Application in 2017
Table Global Herpes Zoster Infection Treatment Revenue Forecast by Application (2018-2023)
Figure Global Herpes Zoster Infection Treatment Market Share Forecast by Application (2018-2023)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Diagnostic centers Revenue Growth Rate (2013-2018)
Figure Global Home Care Revenue Growth Rate (2013-2018)
Figure Global Herpes Zoster Infection Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Herpes Zoster Infection Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Herpes Zoster Infection Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
Figure Europe Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
Figure South America Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)